{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T23:03:05Z","timestamp":1795215785975,"version":"4.10.3"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.cancergencyto.2007.11.011","type":"journal-article","created":{"date-parts":[[2008,2,25]],"date-time":"2008-02-25T16:32:41Z","timestamp":1203957161000},"page":"93-99","source":"Crossref","is-referenced-by-count":21,"title":["8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110\/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality"],"prefix":"10.1016","volume":"181","author":[{"given":"Tae Sung","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewoo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Ick","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungwook","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borum","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Rak","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2007.11.011_bib1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.beha.2005.07.013","article-title":"Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapy","volume":"19","author":"Gotlib","year":"2006","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.cancergencyto.2007.11.011_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000085559","article-title":"Molecular classification and pathogenesis of eosinophilic disorders: 2005 update","volume":"114","author":"Gotlib","year":"2005","journal-title":"Acta Haematol"},{"key":"10.1016\/j.cancergencyto.2007.11.011_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.leu.2404955","article-title":"Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms","volume":"22","author":"Tefferi","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2007.11.011_bib4","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.leu.2402556","article-title":"Tyrosine kinase fusion genes in chronic myeloproliferative diseases","volume":"16","author":"Cross","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2007.11.011_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000046639","article-title":"The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1","volume":"107","author":"Macdonald","year":"2002","journal-title":"Acta Haematol"},{"key":"10.1016\/j.cancergencyto.2007.11.011_bib6","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood.V85.7.1881.bloodjournal8571881","article-title":"A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia\/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity","volume":"85","author":"Inhorn","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2007.11.011_bib7","article-title":"ISCN 2005: an international system for human cytogenetic nomenclature (2005)","year":"2005"},{"key":"10.1016\/j.cancergencyto.2007.11.011_bib8","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1182\/blood.V95.5.1788.005k15_1788_1796","article-title":"FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33)","volume":"95","author":"Guasch","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2007.11.011_bib9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1600-0609.2006.00723.x","article-title":"A biphenotypic transformation of 8p11 myeloproliferative syndrome with CEP1\/FGFR1 fusion gene","volume":"77","author":"Yamamoto","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cancergencyto.2007.11.011_bib10","series-title":"Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours","year":"2001"},{"key":"10.1016\/j.cancergencyto.2007.11.011_bib11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0165-4608(83)90088-2","article-title":"Novel reciprocal translocation between chromosomes 8 and 9 found in a patient with myeloproliferative disorder","volume":"9","author":"Friedhoff","year":"1983","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2007.11.011_bib12","first-page":"265","article-title":"Philadelphia chromosome-negative chronic myelogenous leukemia in a child with t(8;9)(p11 or 12;q34)","volume":"5","author":"Lewis","year":"1983","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.cancergencyto.2007.11.011_bib13","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/jmg.22.5.398","article-title":"Reciprocal translocation between chromosomes 8 and 9 in atypical chronic myeloid leukemia","volume":"22","author":"Oscier","year":"1985","journal-title":"J Med Genet"},{"key":"10.1016\/j.cancergencyto.2007.11.011_bib14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.1992.tb08225.x","article-title":"t(8;9)(p11;q32) in atypical chronic myeloid leukaemia: a new cytogenetic-clinicopathologic association?","volume":"81","author":"Jotterand Bellomo","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2007.11.011_bib15","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1365-2141.1996.00386.x","article-title":"Chronic myelomonocytic leukaemia with t(8;9)(p11;q34) in childhood: an example of the 8p11 myeloproliferative disorder?","volume":"92","author":"Nakayama","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2007.11.011_bib16","first-page":"1252","article-title":"A young child with acquired t(8;9)(p11;q34): additional proof that 8p11 is involved in mixed myeloid\/T lymphoid malignancies","volume":"10","author":"van den Berg","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2007.11.011_bib17","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/sj.onc.1201601","article-title":"t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12","volume":"16","author":"Chaffanet","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergencyto.2007.11.011_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/gcc.1177","article-title":"Identification of four new translocations involving FGFR1 in myeloid disorders","volume":"32","author":"Sohal","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2007.11.011_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00277-004-0977-1","article-title":"Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid information","volume":"84","author":"Bacher","year":"2005","journal-title":"Ann Hematol"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460807007674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460807007674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T07:33:48Z","timestamp":1588404828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460807007674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0165460807007674"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2007.11.011","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}